<DOC>
	<DOCNO>NCT02091401</DOCNO>
	<brief_summary>The trial test equivalence repeat bolus protocol magnesium sulfate administer SpringfusorÂ® control pump continuous intravenous regimen . The goal pharmacokinetic study assess pharmacological equivalence serum magnesium sulfate concentration obtain treatment severe preeclampsia continuous intravenous Springfusor repeat bolus regimen . The study also document clinical outcome , efficacy acceptability treatment patient staff .</brief_summary>
	<brief_title>A Trial Comparing Treatment With Springfusor Infusion Pump IV Magnesium Sulfate Regimen</brief_title>
	<detailed_description />
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>Exhibit systolic blood pressure &gt; 160mm Hg OR diastolic pressure &gt; 110 mm Hg ( two time 30 minute ) ( A single high pressure could accept clinical team felt magnesium sulfate therapy initiate without wait 30 minute ) . Exhibit proteinuria &gt; 1+ ; Have give birth , &lt; 24h postpartum Be assess enrol physician benefit magnesium sulfate therapy Agree comply study procedure Be &gt; 18 year age Give inform consent study participation Eclamptic seizing time enrollment Received magnesium sulfate therapy 24h prior study enrollment Known serum creatinine &gt; 1.2 mg/dL . ( Subject may enrol prior knowledge serum creatinine would withdraw &gt; 1.2 mg/dL order proper dose adjustment .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>magnesium sulfate</keyword>
</DOC>